Yong Man Kim

Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial

Dalsan You, Myoung‐jin Jang, Geehyun Song et al. · Cytotherapy · 2021 · 33 citations

Medicine, Urology, Regenerative Medicine +15

A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer

Eo Jin Kim, Yong‐Hee Cho, Dong Ha Kim et al. · Cancer Research and Treatment · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Two‐year efficacy of <scp>SNK01</scp> plus pembrolizumab for non‐small cell lung cancer: Expanded observations from a phase <scp>I/IIa</scp> randomized controlled trial

Hyung Park, Yong Man Kim, Jae Seob Jung et al. · Thoracic Cancer · 2022 · 14 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

C. Gandarias Zúñiga, Blanca Isaura Acosta, Cesar Alejandro Amescua et al. · Alzheimer s Research & Therapy · 2025 · 10 citations · Full text

Life Sciences, Immunology, Neuroscience +17